Not Yet Recruiting Retinal Clinical Assessment With AI-derived Quantitative Information NCT07291960 Conditions AMD, Cardiovascular Diseases, Cup-to-disc Ratio Bigger Than 0.5, +22 more Locations Not specified View Trial Details
Not Yet Recruiting An Interpretable Fundus Diseases Report Generating System Based On Weakly Labelings NCT06918028 Conditions Age Related Macular Degeneration, Cardiovascular Diseases, Choroid Diseases, +21 more Locations Zhongshan Ophthalmic Center — Guangzhou, Guangdong, China View Trial Details
Completed Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia NCT01217944 Conditions Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +9 more Locations Novartis Investigative Site — Vienna, Austria Novartis Investigative Site — Linz, Upper Austria, Austria Novartis Investigative Site — Vancouver, British Columbia, Canada Novartis Investigative Site — Montreal, Quebec, Canada View all 74 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy NCT00470977 Conditions Abnormalities, Multiple, Angiomatosis, BEST VITELLIFORM MACULAR DYSTROPHY, MULTIFOCAL (Disorder), +45 more Locations Lenox Hill Hospital/Manhattan Eye Ear and Throat Institute — New York, United States Lenox Hill Hospital/Manhattan Eye, Ear & Throat Institute — New York, United States View Trial Details
Completed Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD) NCT00407719 Conditions Choroid Diseases, Choroidal Neovascularization, Degenerative Myopia, +10 more Locations Not specified View Trial Details
